NO995711L - Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister - Google Patents
Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonisterInfo
- Publication number
- NO995711L NO995711L NO995711A NO995711A NO995711L NO 995711 L NO995711 L NO 995711L NO 995711 A NO995711 A NO 995711A NO 995711 A NO995711 A NO 995711A NO 995711 L NO995711 L NO 995711L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- optionally substituted
- group
- compound
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710750.2A GB9710750D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
IT002354 IT1295358B1 (it) | 1997-10-17 | 1997-10-17 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
ITMI972775 IT1296976B1 (it) | 1997-12-16 | 1997-12-16 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
PCT/EP1998/003014 WO1998052942A1 (en) | 1997-05-23 | 1998-05-18 | Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995711D0 NO995711D0 (no) | 1999-11-22 |
NO995711L true NO995711L (no) | 2000-01-19 |
Family
ID=27268859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995711A NO995711L (no) | 1997-05-23 | 1999-11-22 | Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0983262B1 (pt) |
JP (1) | JP2002500645A (pt) |
CN (1) | CN1264378A (pt) |
AP (1) | AP9901695A0 (pt) |
AR (1) | AR012732A1 (pt) |
AT (1) | ATE244711T1 (pt) |
AU (1) | AU8209898A (pt) |
BG (1) | BG104009A (pt) |
BR (1) | BR9809652A (pt) |
CA (1) | CA2291111A1 (pt) |
CO (1) | CO4950515A1 (pt) |
DE (1) | DE69816290T2 (pt) |
DZ (1) | DZ2498A1 (pt) |
EA (1) | EA199901062A1 (pt) |
ES (1) | ES2201509T3 (pt) |
HU (1) | HUP0002300A3 (pt) |
ID (1) | ID22876A (pt) |
IL (1) | IL133036A0 (pt) |
MA (1) | MA26501A1 (pt) |
NO (1) | NO995711L (pt) |
OA (1) | OA11515A (pt) |
PE (1) | PE75199A1 (pt) |
PL (1) | PL336942A1 (pt) |
SK (1) | SK159299A3 (pt) |
TR (1) | TR199902883T2 (pt) |
WO (1) | WO1998052942A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9825554D0 (en) | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
NZ511777A (en) * | 1998-11-20 | 2003-12-19 | Smithkline Beecham S | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
US6780875B2 (en) * | 1998-11-20 | 2004-08-24 | Smithkline Beecham S.P.A. | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
US6413982B1 (en) | 1999-03-29 | 2002-07-02 | Neurogen Corporation | 4-substituted quinoline derivatives |
AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
WO2002013825A1 (en) * | 2000-08-11 | 2002-02-21 | Smithkline Beecham P.L.C. | Novel pharmaceutical use of quinnoline derivatives |
JP2004517062A (ja) * | 2000-11-13 | 2004-06-10 | グラクソスミスクライン・ソシエタ・ペル・アチオニ | Nk−3およびnk−2アンタゴニストとしてのキノリン誘導体 |
GB0028964D0 (en) * | 2000-11-28 | 2001-01-10 | Smithkline Beecham Spa | Novel compounds |
AU2002226356A1 (en) * | 2000-11-28 | 2002-06-11 | Glaxosmithkline S.P.A. | Quinoline derivatives as nk-3 antagonists |
US6540733B2 (en) | 2000-12-29 | 2003-04-01 | Corazon Technologies, Inc. | Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion |
WO2002083663A1 (en) * | 2001-04-11 | 2002-10-24 | Glaxosmithkline S.P.A. | Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
GB0109122D0 (en) * | 2001-04-11 | 2001-05-30 | Smithkline Beecham Spa | Novel compounds |
MY134211A (en) * | 2001-05-18 | 2007-11-30 | Smithkline Beecham Corp | Novel use |
GB0425075D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
GB0425076D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
GB0425077D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
EP1891012A2 (en) * | 2005-06-03 | 2008-02-27 | AstraZeneca AB | Quinoline derivatives as nk3 anatgonists |
GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
AR057130A1 (es) | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
DE202007017299U1 (de) * | 2007-12-12 | 2009-04-23 | Drebo Werkzeugfabrik Gmbh | Bohrer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0804419T3 (da) * | 1994-05-27 | 2003-11-24 | Glaxosmithkline Spa | Quinolinderivater som tachykinin NK 3-receptor-antagonister |
AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
-
1998
- 1998-05-18 AP APAP/P/1999/001695A patent/AP9901695A0/en unknown
- 1998-05-18 PL PL98336942A patent/PL336942A1/xx unknown
- 1998-05-18 BR BR9809652-4A patent/BR9809652A/pt not_active IP Right Cessation
- 1998-05-18 HU HU0002300A patent/HUP0002300A3/hu unknown
- 1998-05-18 TR TR1999/02883T patent/TR199902883T2/xx unknown
- 1998-05-18 WO PCT/EP1998/003014 patent/WO1998052942A1/en not_active Application Discontinuation
- 1998-05-18 ES ES98932069T patent/ES2201509T3/es not_active Expired - Lifetime
- 1998-05-18 IL IL13303698A patent/IL133036A0/xx unknown
- 1998-05-18 CA CA002291111A patent/CA2291111A1/en not_active Abandoned
- 1998-05-18 ID IDW991432A patent/ID22876A/id unknown
- 1998-05-18 EP EP98932069A patent/EP0983262B1/en not_active Expired - Lifetime
- 1998-05-18 JP JP54996798A patent/JP2002500645A/ja not_active Ceased
- 1998-05-18 EA EA199901062A patent/EA199901062A1/ru unknown
- 1998-05-18 DE DE69816290T patent/DE69816290T2/de not_active Expired - Fee Related
- 1998-05-18 AT AT98932069T patent/ATE244711T1/de not_active IP Right Cessation
- 1998-05-18 CN CN98807356A patent/CN1264378A/zh active Pending
- 1998-05-18 SK SK1592-99A patent/SK159299A3/sk unknown
- 1998-05-18 AU AU82098/98A patent/AU8209898A/en not_active Abandoned
- 1998-05-19 DZ DZ980108A patent/DZ2498A1/xx active
- 1998-05-20 PE PE1998000398A patent/PE75199A1/es not_active Application Discontinuation
- 1998-05-21 MA MA25086A patent/MA26501A1/fr unknown
- 1998-05-21 AR ARP980102363A patent/AR012732A1/es not_active Application Discontinuation
- 1998-05-22 CO CO98029024A patent/CO4950515A1/es unknown
-
1999
- 1999-11-22 NO NO995711A patent/NO995711L/no not_active Application Discontinuation
- 1999-11-23 OA OA9900253A patent/OA11515A/en unknown
- 1999-12-14 BG BG104009A patent/BG104009A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BG104009A (en) | 2000-07-31 |
ATE244711T1 (de) | 2003-07-15 |
IL133036A0 (en) | 2001-03-19 |
PL336942A1 (en) | 2000-07-17 |
BR9809652A (pt) | 2001-09-11 |
AU8209898A (en) | 1998-12-11 |
SK159299A3 (en) | 2000-06-12 |
TR199902883T2 (xx) | 2000-05-22 |
WO1998052942A1 (en) | 1998-11-26 |
OA11515A (en) | 2004-02-04 |
DZ2498A1 (fr) | 2003-01-25 |
ES2201509T3 (es) | 2004-03-16 |
HUP0002300A2 (hu) | 2001-06-28 |
EP0983262B1 (en) | 2003-07-09 |
ID22876A (id) | 1999-12-16 |
DE69816290T2 (de) | 2004-05-27 |
EA199901062A1 (ru) | 2000-08-28 |
CA2291111A1 (en) | 1998-11-26 |
CO4950515A1 (es) | 2000-09-01 |
PE75199A1 (es) | 1999-10-22 |
JP2002500645A (ja) | 2002-01-08 |
AR012732A1 (es) | 2000-11-08 |
NO995711D0 (no) | 1999-11-22 |
EP0983262A1 (en) | 2000-03-08 |
CN1264378A (zh) | 2000-08-23 |
HUP0002300A3 (en) | 2002-01-28 |
AP9901695A0 (en) | 1999-12-31 |
MA26501A1 (fr) | 2004-12-20 |
DE69816290D1 (de) | 2003-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995711L (no) | Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister | |
AP9801238A0 (en) | Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 (NK-3)- and neurokinin 2 (NK-2) receptor antagonists. | |
EA200200942A1 (ru) | Фармацевтические композиции, содержащие производные 3-аминоазетидина, новые производные и способ их получения | |
BG104248A (en) | Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides | |
EA200100428A1 (ru) | Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты) | |
MX9504349A (es) | Derivados de aroilpiperidina. | |
CY1107221T1 (el) | Παραγωγα τριαζολιου ως ανταγωνιστες υποδοχεα ταχυκινινης | |
EA200602060A1 (ru) | Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы | |
AR007077A1 (es) | Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento | |
ES2091615T3 (es) | Derivados de indol fungicidas. | |
WO2002034754A3 (en) | Benzoxazinone derivatives, their preparation and use | |
ATE348813T1 (de) | Chinolinderivate als nk-2 und nk-3 rezeptor- liganden | |
AR005338A1 (es) | Derivados acetidinalquilicos de heterociclos con nitrogeno n-sustituido o sales farmaceuticamente aceptables de los mismos, un procedimiento paraprepararlos, composiciones farmaceuticas que los comprenden, uso de dichos derivados, sales y composiciones, y compuestos utilizables como intermedios | |
NO964698L (no) | Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase | |
EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
DK1034174T3 (da) | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer | |
AR023111A1 (es) | Derivados de sulfonamida utiles como antagonistas del receptor 5-ht7, un procedimiento para su preparacion y composicion farmaceutica que los comprenden | |
ATE259359T1 (de) | Benzoxazol-derivate zur verwendung als integrin- inhibitoren | |
MEP12408A (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors | |
DK0701551T3 (da) | 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister | |
NO20062761L (no) | Ny fremgangsmate for fremstilling av 3-fluorinterte quinoliner | |
EA200400469A1 (ru) | Замещенные производные алкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции | |
ES2186365T3 (es) | Derivados de tetrahidroisoquinolina como moduladores de los receptores d3 de la dopamina. | |
EA200300302A1 (ru) | Новые производные индолина, способ их получения и фармацевтические композиции, содержащие их | |
GB0427491D0 (en) | Process and compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |